Back
Loncar Cancer Immunotherapy ETF Stock Predictions
Sponsored
CNCR
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Sell
50
CNCR
Loncar Cancer Immunotherapy ETF
Last Price:
15.44
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Loncar Cancer Immunotherapy ETF Stock Forecast
- Over the next 52 weeks, Loncar Cancer Immunotherapy ETF has on average historically fallen by 3.2% based on the past 8 years of stock performance.
- Loncar Cancer Immunotherapy ETF has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Loncar Cancer Immunotherapy ETF Stock Undervalued?
The current Loncar Cancer Immunotherapy ETF [CNCR] share price is $15.44. The Score for CNCR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Loncar Cancer Immunotherapy ETF Stock Go Up Next Year?
- Over the next 52 weeks, Loncar Cancer Immunotherapy ETF has on average historically fallen by 3.2% based on the past 8 years of stock performance.
Loncar Cancer Immunotherapy ETF Stock Rating
Sell
50
Loncar Cancer Immunotherapy ETF (CNCR)
is a Sell
Is Loncar Cancer Immunotherapy ETF overpriced?
- Loncar Cancer Immunotherapy ETF has fallen lower in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Loncar Cancer Immunotherapy ETF Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:
52-Week Data
52-Week High:
17.96
52-Week Low:
9.22
Prediction Charts
Market Cap:
0
Price in USD:
15.44
Volume:
82.84K
Beta:
1.13
Technical Analysis
SMA50:
15.92
SMA100:
14.88
SMA200:
13.07
52-Wk Change:
19.27%
Stock Predictions
-
Is Loncar Cancer Immunotherapy ETF stock public?
Yes, Loncar Cancer Immunotherapy ETF is a publicly traded company. -
What is the Loncar Cancer Immunotherapy ETF stock quote today?
The Loncar Cancer Immunotherapy ETF stock price is 15.44 USD today. -
How to buy Loncar Cancer Immunotherapy ETF stock online?
You can buy Loncar Cancer Immunotherapy ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-12 | 15.91 | 15.64 | 15.91 | 15.32 |
Apr-15 | 15.59 | 15.01 | 15.59 | 15.00 |
Apr-16 | 14.97 | 14.67 | 15.00 | 14.67 |
Apr-17 | 14.89 | 14.57 | 14.89 | 14.57 |
Apr-18 | 14.58 | 14.36 | 14.63 | 14.36 |
Apr-19 | 14.30 | 14.11 | 14.49 | 13.92 |
Apr-22 | 14.18 | 14.21 | 14.48 | 14.05 |
Apr-23 | 14.44 | 14.48 | 14.65 | 14.44 |
Apr-24 | 14.53 | 14.23 | 14.53 | 14.23 |
Apr-25 | 14.26 | 13.95 | 14.26 | 13.77 |
Apr-26 | 13.97 | 14.39 | 14.43 | 13.94 |
Apr-29 | 14.65 | 15.03 | 15.27 | 14.65 |
Apr-30 | 15.07 | 14.76 | 15.10 | 14.76 |
May-1 | 15.00 | 15.44 | 15.83 | 14.94 |
Loncar Cancer Immunotherapy ETF Earnings
Data Unavailable
Loncar Cancer Immunotherapy ETF Forecast Revenue Growth
Data Unavailable
* Loncar Cancer Immunotherapy ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.